Results 111 to 120 of about 612,706 (397)

Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.

open access: yesGastroenterology, 2015
BACKGROUND & AIMS No adjuvant therapy has been shown to extend the survival of patients with hepatocellular carcinoma (HCC) receiving curative treatment.
J. Lee   +10 more
semanticscholar   +1 more source

Intra-operative blood salvage in total hip and knee arthroplasty [PDF]

open access: yes, 2016
Purpose To review records of 371 patients who underwent total hip or knee arthroplasty (THA or TKA) with intra-operative blood salvage to determine the allogeneic blood transfusion rate and the predictors for allogeneic blood transfusion. Methods Records
Beller, Elaine   +3 more
core   +1 more source

Bioengineering a Patient‐Derived Vascularized Lung Tumor‐on‐Chip Model to Decipher Immunomodulation by the Endothelium

open access: yesAdvanced Healthcare Materials, EarlyView.
Most in vitro cancer models lack cellular diversity, functional complexity, and clinical relevance. This work highlights the generation of an innovative dynamic tetraculture with autologous patient‐derived cells within a vascularized tumor‐on‐chip, as well as the recapitulation of endothelial anergy features induced by the tumor microenvironment ...
Christine Lansche   +16 more
wiley   +1 more source

Establishment and neural differentiation of neural crest‐derived stem cells from human dental pulp in serum‐free conditions

open access: yesStem Cells Translational Medicine, 2020
The potential of obtaining cell cultures with neural crest resemblance (neural crest‐derived stem cells [NCSCs]) from dental‐related tissues, including human dental pulp cells (hDPCs), has been discussed in the literature.
Oscar O. Solis‐Castro   +2 more
doaj   +1 more source

Phase 1 Trial of Vaccination with Autologous Tumor Cells and Antisense Directed Against the Insulin Growth Factor Type 1 Receptor (IGF-1R AS ODN) in Patients with Recurrent Glioblastoma [PDF]

open access: yes, 2018
Background: Extending a previous Phase I study, we report the results of a second Phase I autologous tumor cell vaccination trial for patients with recurrent glioblastomas (IND 14379-101, NCT01550523). Methods: Following surgery, subjects were treated by
Andrews MD, David W.   +3 more
core   +2 more sources

Patient-specific and physiological load sustaining synthetic graft substitutes for fusion of critically sized segmental bone defects [PDF]

open access: yesarXiv, 2018
Critically sized defects are currently treated via autologous or allograft bone grafting, distraction osteogenesis, and membrane induction. However, these methods have major weaknesses which encourage the development of synthetic bone graft substitutes.
arxiv  

Engineering Assembloids to Mimic Graft‐Host Skeletal Muscle Interaction

open access: yesAdvanced Healthcare Materials, EarlyView.
This study develops a graft‐host skeletal muscle assembloid model combining neuromuscular organoids with tissue‐engineered constructs. Pre‐seeding decellularized muscles with myogenic cells enhances cell migration and axon invasion from the organoid. The model exhibits regenerative capacity following acute damage, advancing the understanding of human ...
Lucia Rossi   +13 more
wiley   +1 more source

Shaping the Breast in Aesthetic and Reconstructive Breast Surgery: An Easy Three-Step Principle. Part II - Breast Reconstruction after Total Mastectomy [PDF]

open access: yes, 2009
This is Part II of four parts describing the three-step principle being applied in reconstructive and aesthetic breast surgery. Part I explains how to analyze a problematic breast by understanding the main anatomical features of a breast and how they ...
Blondeel, Phillip   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy